Pakistan Drugmakers Bet $500 Million on Exports as Economy Slows

emerging-markets,exports,emerging-markets-economics,global-trade,pharmaceutical,science,government,regulation,brics,megacity

Faseeh Mangi

Spiraling Power Bills Overtake Rent Costs for Some in Pakistan

Company Overview

Pakistan

Exports

pharmaceutical

Regulation

Europe

India

Bangladesh

Karachi

Chief Executive Officer

Asia

Currency

Government

Investing

Cambodia

Myanmar

Middle East

Markets

Industrials

C-suite

Healthcare

Emerging Markets

Africa

BRICS

Science

Switzerland

Megacity

Emerging Markets Economics

Global Trade

Pakistani pharmaceutical companies are racing to retool factories to tap markets from the Persian Gulf to Europe in a bid to boost exports.

Pills On A Production Line

Bloomberg subscribers can save articles and view them from any device.

Upgrade to an unlimited subscription to save articles and view them from anywhere.

Bloomberg subscribers can send up to {count} articles a month to anyone to read for free, including non-subscribers.

Upgrade your subscription to send up to {count} articles a month to anyone to read for free, including non-subscribers.

Copy article link

Hello,<p>A Bloomberg.com subscriber thought you might want to read this story. To read it, all you need to do is click on the link – no subscription necessary. (Please note the link will only be valid for {days} days.)

Email article link

Please try again. If the problem persists, please contact customer support.

Something went wrong

We've doubled your gift articles this month. Share up to {count} articles with friends, family or colleagues.

As a subscriber, you can gift up to {count} articles this month. The recipient can read the full article for free – no subscription necessary.

As a subscriber, you can gift up to {count} articles each month. The recipient can read the full article for free – no subscription necessary.